Vinblastine

Generic name: Pronounced as (vin blas' teen)
Brand names
  • Velban®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 06/15/2013

Vinblastine should be administered only into a vein. However, it may leak into surrounding tissue causing severe irritation or damage. Your doctor or nurse will monitor your administration site for this reaction. If you experience any of the following symptoms, call your doctor immediately: pain, itching, redness, swelling, blisters, or sores in the place where the medication was injected.

Vinblastine should be given only under the supervision of a doctor with experience in the use of chemotherapy medications.

Vinblastine is used in combination with other chemotherapy drugs to treat Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma (types of cancer that begin in a type of white blood cell that normally fights infection), and cancer of the testicles. It is also used to treat Langerhans cell histiocytosis (histiocytosis X; Letterer-Siwe disease; a condition in which too many of a certain type of white blood cell grows in parts of the body). It may also be used to treat breast cancer that has not improved after treatment with other medications and gestational trophoblastic tumors (a type of tumor that forms inside a woman's uterus while she is pregnant) that has not improved after surgery or treatment with other medications. Vinblastine is in a class of medications called vinca alkaloids. It works by slowing or stopping the growth of cancer cells in your body.

Vinblastine comes as a powder or solution (liquid) to be injected intravenously (into a vein) by a doctor or nurse in a medical facility. It is usually given once a week. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have.

Your doctor may need to delay your treatment or change your dose if you experience certain side effects. It is important for you to tell your doctor how you are feeling during your treatment with vinblastine injection.

Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.

Vinblastine is also sometimes used to treat bladder cancer, certain types of lung cancer, Kaposi's sarcoma, and certain brain tumors. Talk to your doctor about the risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before receiving vinblastine,

  • tell your doctor and pharmacist if you are allergic to vinblastine, any other medications, or any of the ingredients in vinblastine injection. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: aprepitant (Emend), certain antifungals such as itraconazole (Sporanox) and ketoconazole (Nizoral); clarithromycin (Biaxin, in Prevpac); erythromycin (E.E.S., E-Mycin, others); HIV protease inhibitors including indinavir (Crixivan), nelfinavir (Viracept), and ritonavir (Norvir, in Kaletra); phenytoin (Dilantin), tolterodine (Detrol, Detrol LA). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Tell your doctor and pharmacist about all the medications you are taking so they can check whether any of your medications may increase the risk that you will develop hearing problems during your treatment with vinblastine.

  • tell your doctor if you have an infection. Your doctor will want to treat your infection before you receive vinblastine injection.

  • tell your doctor if you have or have ever had heart or blood vessel disease, including varicose veins (swelling, redness, or pain in a vein in your arms or legs), or lung or liver disease.

  • you should know that vinblastine may interfere with the normal menstrual cycle (period) in women and may temporarily or permanently stop sperm production in men. Tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. You should not become pregnant or breast-feed while you are receiving vinblastine injection. If you become pregnant while receiving vinblastine injection, call your doctor. Vinblastine may harm the fetus.

Unless your doctor tells you otherwise, continue your normal diet.

  • Vinblastine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • constipation

    • nausea

    • vomiting

    • loss of appetite or weight

    • stomach pain

    • diarrhea

    • headache

    • dizziness

    • jaw pain, bone pain, and other aches

    • hair loss

  • Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately or get emergency medical treatment:

    • fever, sore throat, chills, or other signs of infection

    • unusual bleeding or bruising

    • sores in the mouth

    • unusual tiredness or weakness

    • pain, numbness, burning, or tingling in the hands or feet

    • difficulty walking or unsteady walking

    • difficulty breathing

    • hearing loss

    • seizures

    • chest pain

  • Vinblastine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • confusion

  • seizures

  • constipation

  • stomach pain

  • unusual bleeding or bruising

  • fever, sore throat, chills, or other signs of infection

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to vinblastine.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • Vincaleukoblastine Sulfate
  • VLB

Drug Interaction
Repaglinide Repaglinide Vinblastine may decrease the excretion rate of Repaglinide which could result in a higher serum level.
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Vinblastine is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Delavirdine can be decreased when combined with Vinblastine.
Nevirapine Nevirapine The metabolism of Nevirapine can be decreased when combined with Vinblastine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Vinblastine.
Dolasetron Dolasetron The metabolism of Dolasetron can be decreased when combined with Vinblastine.
Aminophylline Aminophylline The metabolism of Aminophylline can be increased when combined with Vinblastine.
Anagrelide Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Vinblastine.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Vinblastine.
Clopidogrel Clopidogrel The risk or severity of bleeding can be increased when Clopidogrel is combined with Vinblastine.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Vinblastine can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The excretion of Conjugated estrogens can be decreased when combined with Vinblastine.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Vinblastine.
Methylergonovine Methylergonovine The metabolism of Vinblastine can be decreased when combined with Methylergometrine.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Vinblastine is combined with Mycophenolic acid.
Paregoric Paregoric The serum concentration of Vinblastine can be increased when it is combined with Morphine.
Penbutolol Penbutolol The metabolism of Acebutolol can be decreased when combined with Vinblastine.
Prednisone Prednisone The risk or severity of adverse effects can be increased when Vinblastine is combined with Prednisone.
Reserpine Reserpine The serum concentration of Vinblastine can be increased when it is combined with Reserpine.
Sumatriptan Sumatriptan The excretion of Sumatriptan can be decreased when combined with Vinblastine.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Vinblastine.
Triamcinolone Triamcinolone The metabolism of Triamcinolone can be increased when combined with Vinblastine.
Doxycycline Injection Doxycycline Injection The metabolism of Vinblastine can be decreased when combined with Doxycycline.
Fluconazole Injection Fluconazole Injection The metabolism of Vinblastine can be decreased when combined with Fluconazole.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Vinblastine.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vinblastine.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be increased when combined with Vinblastine.
Methylprednisolone Injection Methylprednisolone Injection The metabolism of Methylprednisolone can be increased when combined with Vinblastine.
Metoclopramide Injection Metoclopramide Injection The metabolism of Metoclopramide can be decreased when combined with Vinblastine.
Metronidazole Injection Metronidazole Injection The metabolism of Vinblastine can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection The serum concentration of Vinblastine can be increased when it is combined with Morphine.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Vinblastine.
Altretamine Altretamine The metabolism of Amphetamine can be decreased when combined with Vinblastine.
Cyclosporine Cyclosporine Vinblastine may increase the immunosuppressive activities of Cyclosporine.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Vinblastine.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Vinblastine.
Torsemide Torsemide The excretion of Torasemide can be decreased when combined with Vinblastine.
Olanzapine Olanzapine The metabolism of Olanzapine can be decreased when combined with Vinblastine.
Dofetilide Dofetilide The metabolism of Dofetilide can be increased when combined with Vinblastine.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Vinblastine is combined with Hydroxychloroquine.
Orlistat Orlistat The metabolism of Vinblastine can be increased when combined with Orlistat.
Oxcarbazepine Oxcarbazepine The metabolism of Vinblastine can be increased when combined with Oxcarbazepine.
Telmisartan Telmisartan Vinblastine may decrease the excretion rate of Telmisartan which could result in a higher serum level.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Vinblastine is combined with Temozolomide.
Anakinra Anakinra The metabolism of Vinblastine can be increased when combined with Anakinra.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Vinblastine is combined with Linezolid.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Vinblastine.
Trimipramine Trimipramine The metabolism of Trimipramine can be decreased when combined with Vinblastine.
Etanercept Injection Etanercept Injection The metabolism of Vinblastine can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Vinblastine can be increased when combined with Modafinil.
Tenofovir Tenofovir The metabolism of Tenofovir can be decreased when combined with Vinblastine.
Sirolimus Sirolimus The metabolism of Sirolimus can be increased when combined with Vinblastine.
Epinephrine Injection Epinephrine Injection The metabolism of Vinblastine can be decreased when combined with Epinephrine.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Vinblastine.
Escitalopram Escitalopram The metabolism of Escitalopram can be decreased when combined with Vinblastine.
Olmesartan Olmesartan Vinblastine may decrease the excretion rate of Olmesartan which could result in a higher serum level.
Zonisamide Zonisamide The serum concentration of Vinblastine can be increased when it is combined with Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Vinblastine can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be increased when combined with Vinblastine.
Atomoxetine Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Vinblastine.
Ezetimibe Ezetimibe Vinblastine may decrease the excretion rate of Ezetimibe which could result in a higher serum level.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Glatiramer.
Atazanavir Atazanavir The metabolism of Atazanavir can be decreased when combined with Vinblastine.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Vinblastine.
Eletriptan Eletriptan The metabolism of Eletriptan can be decreased when combined with Vinblastine.
Mefloquine Mefloquine The metabolism of Vinblastine can be decreased when combined with Mefloquine.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Vinblastine.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Vinblastine.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Vinblastine.
Aprepitant Aprepitant The metabolism of Vinblastine can be decreased when combined with Aprepitant.
Tegaserod Tegaserod The serum concentration of Tegaserod can be increased when it is combined with Vinblastine.
Progesterone Progesterone The metabolism of Vinblastine can be increased when combined with Progesterone.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vinblastine.
Infliximab Injection Infliximab Injection The metabolism of Vinblastine can be increased when combined with Infliximab.
Protriptyline Protriptyline The metabolism of Protriptyline can be decreased when combined with Vinblastine.
Rifaximin Rifaximin The metabolism of Vinblastine can be increased when combined with Rifaximin.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Vinblastine.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Vinblastine.
Tinidazole Tinidazole Vinblastine may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan The metabolism of Vinblastine can be increased when combined with Bosentan.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Natalizumab.
Erlotinib Erlotinib The serum concentration of Erlotinib can be decreased when it is combined with Vinblastine.
Eszopiclone Eszopiclone The serum concentration of Eszopiclone can be decreased when it is combined with Vinblastine.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Vinblastine.
Solifenacin Solifenacin The metabolism of Solifenacin can be decreased when combined with Vinblastine.
Voriconazole Voriconazole The metabolism of Vinblastine can be decreased when combined with Voriconazole.
Dextroamphetamine Dextroamphetamine The metabolism of Amphetamine can be decreased when combined with Vinblastine.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vinblastine.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vinblastine.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Vinblastine.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Vinblastine.
Deferasirox Deferasirox The metabolism of Vinblastine can be increased when combined with Deferasirox.
Tipranavir Tipranavir The metabolism of Vinblastine can be decreased when combined with Tipranavir.
Felbamate Felbamate The metabolism of Vinblastine can be increased when combined with Felbamate.
Ranolazine Ranolazine The metabolism of Vinblastine can be increased when combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Abatacept can be increased when combined with Vinblastine.
Imatinib Imatinib The metabolism of Imatinib can be decreased when combined with Vinblastine.
Sitagliptin Sitagliptin The serum concentration of Sitagliptin can be increased when it is combined with Vinblastine.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Vinblastine.
Gefitinib Gefitinib The metabolism of Gefitinib can be decreased when combined with Vinblastine.
Paliperidone Paliperidone The serum concentration of Vinblastine can be increased when it is combined with Paliperidone.
Bortezomib Bortezomib The metabolism of Vinblastine can be increased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Clofarabine.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Vinblastine.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Vinblastine.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Vinblastine.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Vinblastine.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Vinblastine.
Posaconazole Posaconazole The metabolism of Vinblastine can be decreased when combined with Posaconazole.
Primaquine Primaquine The metabolism of Vinblastine can be decreased when combined with Primaquine.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Vinblastine.
Darunavir Darunavir The serum concentration of Vinblastine can be increased when it is combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Pemetrexed.
Lisdexamfetamine Lisdexamfetamine The metabolism of Lisdexamfetamine can be decreased when combined with Vinblastine.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Vinblastine.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Vinblastine is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Vinblastine can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Vinblastine.
Lapatinib Lapatinib The metabolism of Vinblastine can be decreased when combined with Lapatinib.
Pegfilgrastim Injection Pegfilgrastim Injection The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinblastine.
Dasatinib Dasatinib The metabolism of Dasatinib can be increased when combined with Vinblastine.
Mexiletine Mexiletine The metabolism of Mexiletine can be decreased when combined with Vinblastine.
Armodafinil Armodafinil The metabolism of Vinblastine can be increased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Azacitidine.
Ivermectin Ivermectin The metabolism of Vinblastine can be increased when combined with Ivermectin.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be increased when combined with Vinblastine.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Vinblastine.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Vinblastine.
Toremifene Toremifene The serum concentration of Vinblastine can be increased when it is combined with Toremifene.
Bexarotene Bexarotene The metabolism of Vinblastine can be increased when combined with Bexarotene.
Budesonide Budesonide The metabolism of Budesonide can be increased when combined with Vinblastine.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Vinblastine can be decreased when combined with Chloramphenicol.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Decitabine.
Etravirine Etravirine The metabolism of Vinblastine can be increased when combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The metabolism of Mitoxantrone can be decreased when combined with Vinblastine.
Desvenlafaxine Desvenlafaxine The metabolism of Vinblastine can be decreased when combined with Desvenlafaxine.
Cevimeline Cevimeline The metabolism of Cevimeline can be decreased when combined with Vinblastine.
Nebivolol Nebivolol The metabolism of Nebivolol can be decreased when combined with Vinblastine.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Vinblastine is combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Bendamustine.
Pilocarpine Pilocarpine The metabolism of Vinblastine can be decreased when combined with Pilocarpine.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Vinblastine.
Certolizumab Injection Certolizumab Injection The metabolism of Certolizumab pegol can be increased when combined with Vinblastine.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Vinblastine.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be increased when combined with Vinblastine.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Vinblastine is combined with Estramustine.
Mitotane Mitotane The metabolism of Vinblastine can be increased when combined with Mitotane.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Vinblastine.
Rufinamide Rufinamide The metabolism of Rufinamide can be increased when combined with Vinblastine.
Silodosin Silodosin The serum concentration of Silodosin can be increased when it is combined with Vinblastine.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Vinblastine.
Romiplostim Injection Romiplostim Injection The risk or severity of peripheral neuropathy can be increased when Romiplostim is combined with Vinblastine.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Vinblastine.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Vinblastine.
Milnacipran Milnacipran The metabolism of Milnacipran can be increased when combined with Vinblastine.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Vinblastine.
Betaxolol Betaxolol The metabolism of Betaxolol can be decreased when combined with Vinblastine.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Vinblastine.
Prasugrel Prasugrel The risk or severity of bleeding can be increased when Prasugrel is combined with Vinblastine.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Vinblastine.
Everolimus Everolimus The metabolism of Vinblastine can be increased when combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be increased when combined with Vinblastine.
Dronedarone Dronedarone The metabolism of Dronedarone can be increased when combined with Vinblastine.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Pralatrexate.
Palonosetron Injection Palonosetron Injection The metabolism of Palonosetron can be decreased when combined with Vinblastine.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be increased when combined with Vinblastine.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Vinblastine.
Topotecan Topotecan The metabolism of Topotecan can be increased when combined with Vinblastine.
Golimumab Injection Golimumab Injection The metabolism of Golimumab can be increased when combined with Vinblastine.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Vinblastine.
Pitavastatin Pitavastatin Vinblastine may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Vinblastine.
Ulipristal Ulipristal The metabolism of Ulipristal can be increased when combined with Vinblastine.
Levonorgestrel Levonorgestrel The metabolism of Levonorgestrel can be increased when combined with Vinblastine.
Oxymorphone Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Vinblastine.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Vinblastine.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Vinblastine.
Tocilizumab Injection Tocilizumab Injection The metabolism of Tocilizumab can be increased when combined with Vinblastine.
Fingolimod Fingolimod Vinblastine may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be increased when combined with Vinblastine.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be increased when combined with Vinblastine.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Vinblastine.
Denileukin Diftitox Injection Denileukin Diftitox Injection The metabolism of Vinblastine can be decreased when combined with Aldesleukin.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Vinblastine.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Belimumab.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be increased when combined with Vinblastine.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Vinblastine.
Linagliptin Linagliptin The metabolism of Vinblastine can be decreased when combined with Linagliptin.
Rilpivirine Rilpivirine The metabolism of Vinblastine can be decreased when combined with Rilpivirine.
Telaprevir Telaprevir The metabolism of Glecaprevir can be decreased when combined with Vinblastine.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Vinblastine can be increased when combined with Cyclophosphamide.
Rivaroxaban Rivaroxaban The serum concentration of Rivaroxaban can be increased when it is combined with Vinblastine.
Ticagrelor Ticagrelor The metabolism of Vinblastine can be decreased when combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Vinblastine.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be increased when combined with Vinblastine.
Vandetanib Vandetanib The metabolism of Vinblastine can be increased when combined with Vandetanib.
Clobazam Clobazam The metabolism of Vinblastine can be increased when combined with Clobazam.
Vemurafenib Vemurafenib The serum concentration of Vinblastine can be increased when it is combined with Vemurafenib.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Belatacept.
Ivacaftor Ivacaftor The metabolism of Vinblastine can be decreased when combined with Ivacaftor.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Vinblastine.
Axitinib Axitinib The metabolism of Axitinib can be increased when combined with Vinblastine.
Crizotinib Crizotinib The metabolism of Crizotinib can be decreased when combined with Vinblastine.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Melphalan.
Cabergoline Cabergoline The metabolism of Vinblastine can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection The metabolism of Vinblastine can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan The serum concentration of Ambrisentan can be increased when it is combined with Vinblastine.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding can be increased when Fondaparinux is combined with Vinblastine.
Pertuzumab Injection Pertuzumab Injection The risk or severity of cardiotoxicity can be increased when Vinblastine is combined with Pertuzumab.
Carfilzomib Injection Carfilzomib Injection The serum concentration of Carfilzomib can be increased when it is combined with Vinblastine.
Iloprost Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Vinblastine.
Enzalutamide Enzalutamide The metabolism of Vinblastine can be increased when combined with Enzalutamide.
Mirabegron Mirabegron The serum concentration of Mirabegron can be increased when it is combined with Vinblastine.
Regorafenib Regorafenib The metabolism of Regorafenib can be decreased when combined with Vinblastine.
Bosutinib Bosutinib The metabolism of Bosutinib can be decreased when combined with Vinblastine.
Corticotropin, Repository Injection Corticotropin, Repository Injection The metabolism of Corticotropin can be increased when combined with Vinblastine.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Vinblastine is combined with Teriflunomide.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Vinblastine.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Vinblastine.
Alogliptin Alogliptin The metabolism of Alogliptin can be decreased when combined with Vinblastine.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Vinblastine is combined with Dimethyl fumarate.
Ponatinib Ponatinib The serum concentration of Ponatinib can be increased when it is combined with Vinblastine.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be increased when combined with Vinblastine.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Vinblastine.
Apixaban Apixaban The serum concentration of Apixaban can be increased when it is combined with Vinblastine.
Canagliflozin Canagliflozin The serum concentration of Canagliflozin can be increased when it is combined with Vinblastine.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be increased when combined with Vinblastine.
Trametinib Trametinib The metabolism of Vinblastine can be increased when combined with Trametinib.
Dolutegravir Dolutegravir The serum concentration of Dolutegravir can be increased when it is combined with Vinblastine.
Afatinib Afatinib The serum concentration of Vinblastine can be increased when it is combined with Afatinib.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be increased when combined with Vinblastine.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Vinblastine.
Perampanel Perampanel The metabolism of Perampanel can be increased when combined with Vinblastine.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Vinblastine.
Lomitapide Lomitapide The metabolism of Vinblastine can be decreased when combined with Lomitapide.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Obinutuzumab.
Simeprevir Simeprevir The metabolism of Simeprevir can be decreased when combined with Vinblastine.
Sofosbuvir Sofosbuvir The serum concentration of Sofosbuvir can be increased when it is combined with Vinblastine.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Vinblastine.
Apremilast Apremilast The metabolism of Apremilast can be increased when combined with Vinblastine.
Ceritinib Ceritinib The metabolism of Ceritinib can be decreased when combined with Vinblastine.
Siltuximab Injection Siltuximab Injection The metabolism of Siltuximab can be increased when combined with Vinblastine.
Eslicarbazepine Eslicarbazepine The metabolism of Vinblastine can be increased when combined with Eslicarbazepine.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Belinostat.
Idelalisib Idelalisib The metabolism of Idelalisib can be increased when combined with Vinblastine.
Testosterone Injection Testosterone Injection The metabolism of Vinblastine can be increased when combined with Testosterone.
Oritavancin Injection Oritavancin Injection The metabolism of Vinblastine can be increased when combined with Oritavancin.
Vorapaxar Vorapaxar The serum concentration of Vinblastine can be increased when it is combined with Vorapaxar.
Hydrocodone Hydrocodone The metabolism of Hydrocodone can be decreased when combined with Vinblastine.
Suvorexant Suvorexant The serum concentration of Vinblastine can be increased when it is combined with Suvorexant.
Edoxaban Edoxaban The serum concentration of Edoxaban can be increased when it is combined with Vinblastine.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Vinblastine.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Blinatumomab.
Caspofungin Injection Caspofungin Injection The excretion of Caspofungin can be decreased when combined with Vinblastine.
Methamphetamine Methamphetamine The metabolism of Metamfetamine can be decreased when combined with Vinblastine.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Vinblastine.
Lanreotide Injection Lanreotide Injection The metabolism of Vinblastine can be decreased when combined with Lanreotide.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Vinblastine is combined with Pirfenidone.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Vinblastine.
Secukinumab Injection Secukinumab Injection The metabolism of Secukinumab can be increased when combined with Vinblastine.
Risperidone Injection Risperidone Injection The metabolism of Risperidone can be decreased when combined with Vinblastine.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Vinblastine.
Lenvatinib Lenvatinib The metabolism of Lenvatinib can be increased when combined with Vinblastine.
Panobinostat Panobinostat The metabolism of Panobinostat can be increased when combined with Vinblastine.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Vinblastine.
Deoxycholic Acid Injection Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Vinblastine which could result in a lower serum level and potentially a reduction in efficacy.
Isavuconazonium Injection Isavuconazonium Injection The serum concentration of Vinblastine can be increased when it is combined with Isavuconazonium.
Sonidegib Sonidegib The metabolism of Sonidegib can be increased when combined with Vinblastine.
Flibanserin Flibanserin The serum concentration of Vinblastine can be increased when it is combined with Flibanserin.
Rolapitant Rolapitant The serum concentration of Vinblastine can be increased when it is combined with Rolapitant.
Prednisolone Prednisolone The metabolism of Prednisolone can be increased when combined with Vinblastine.
Daclatasvir Daclatasvir The serum concentration of Vinblastine can be increased when it is combined with Daclatasvir.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Vinblastine.
Ziprasidone Injection Ziprasidone Injection The metabolism of Ziprasidone can be decreased when combined with Vinblastine.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Vinblastine.
Eluxadoline Eluxadoline The serum concentration of Eluxadoline can be increased when it is combined with Vinblastine.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be increased when combined with Vinblastine.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be increased when combined with Vinblastine.
Osimertinib Osimertinib The metabolism of Osimertinib can be increased when combined with Vinblastine.
Alectinib Alectinib The metabolism of Alectinib can be increased when combined with Vinblastine.
Ixazomib Ixazomib The metabolism of Ixazomib can be increased when combined with Vinblastine.
Rifapentine Rifapentine The metabolism of Vinblastine can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Vinblastine can be increased when combined with Lesinurad.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The metabolism of Vinblastine can be decreased when combined with Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The metabolism of Dexamethasone can be increased when combined with Vinblastine.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Vinblastine.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Ixekizumab.
Venetoclax Venetoclax The metabolism of Venetoclax can be increased when combined with Vinblastine.
Cobicistat Cobicistat The metabolism of Vinblastine can be decreased when combined with Cobicistat.
Selexipag Selexipag The serum concentration of Selexipag can be increased when it is combined with Vinblastine.
Obeticholic Acid Obeticholic Acid The risk or severity of adverse effects can be increased when Vinblastine is combined with Obeticholic acid.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Vinblastine.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Vinblastine.
Ribociclib Ribociclib The metabolism of Ribociclib can be decreased when combined with Vinblastine.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Brodalumab.
Brigatinib Brigatinib The metabolism of Vinblastine can be increased when combined with Brigatinib.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Vinblastine.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Vinblastine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Vinblastine.
Deflazacort Deflazacort The metabolism of Deflazacort can be increased when combined with Vinblastine.
Ocrelizumab Injection Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Vinblastine.
Sarilumab Injection Sarilumab Injection The metabolism of Sarilumab can be increased when combined with Vinblastine.
Midostaurin Midostaurin The metabolism of Vinblastine can be increased when combined with Midostaurin.
Neratinib Neratinib The serum concentration of Vinblastine can be increased when it is combined with Neratinib.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Guselkumab.
Enasidenib Enasidenib The metabolism of Vinblastine can be increased when combined with Enasidenib.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vinblastine.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be increased when combined with Vinblastine.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be increased when combined with Vinblastine.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be increased when combined with Vinblastine.
Betrixaban Betrixaban The serum concentration of Betrixaban can be increased when it is combined with Vinblastine.
Acalabrutinib Acalabrutinib The metabolism of Acalabrutinib can be increased when combined with Vinblastine.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Vinblastine.
Letermovir Letermovir The metabolism of Letermovir can be decreased when combined with Vinblastine.
Tetrabenazine Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Vinblastine.
Ertugliflozin Ertugliflozin The serum concentration of Ertugliflozin can be increased when it is combined with Vinblastine.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Vinblastine.
Apalutamide Apalutamide The serum concentration of Vinblastine can be decreased when it is combined with Apalutamide.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Vinblastine is combined with Penicillamine.
Fostamatinib Fostamatinib The metabolism of Vinblastine can be decreased when combined with Fostamatinib.
Avatrombopag Avatrombopag The serum concentration of Avatrombopag can be increased when it is combined with Vinblastine.
Baricitinib Baricitinib The metabolism of Baricitinib can be increased when combined with Vinblastine.
Lofexidine Lofexidine The metabolism of Lofexidine can be decreased when combined with Vinblastine.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Vinblastine.
Encorafenib Encorafenib The metabolism of Encorafenib can be decreased when combined with Vinblastine.
Binimetinib Binimetinib The serum concentration of Binimetinib can be increased when it is combined with Vinblastine.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be increased when combined with Vinblastine.
Lusutrombopag Lusutrombopag The serum concentration of Lusutrombopag can be increased when it is combined with Vinblastine.
Elagolix Elagolix The serum concentration of Elagolix can be increased when it is combined with Vinblastine.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Vinblastine.
Dacomitinib Dacomitinib The serum concentration of Dacomitinib can be increased when it is combined with Vinblastine.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Vinblastine.
Omadacycline Omadacycline The serum concentration of Omadacycline can be increased when it is combined with Vinblastine.
Sarecycline Sarecycline The serum concentration of Vinblastine can be increased when it is combined with Sarecycline.
Stiripentol Stiripentol The metabolism of Vinblastine can be decreased when combined with Stiripentol.
Talazoparib Talazoparib The serum concentration of Talazoparib can be increased when it is combined with Vinblastine.
Gilteritinib Gilteritinib The metabolism of Gilteritinib can be decreased when combined with Vinblastine.
Glasdegib Glasdegib The serum concentration of Glasdegib can be increased when it is combined with Vinblastine.
Larotrectinib Larotrectinib The serum concentration of Larotrectinib can be increased when it is combined with Vinblastine.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of peripheral neuropathy can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vinblastine.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be increased when combined with Vinblastine.
Rifamycin Rifamycin The metabolism of Rifamycin can be increased when combined with Vinblastine.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Vinblastine.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Emapalumab can be increased when combined with Vinblastine.
Siponimod Siponimod The metabolism of Siponimod can be increased when combined with Vinblastine.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Vinblastine.
Erdafitinib Erdafitinib The serum concentration of Vinblastine can be increased when it is combined with Erdafitinib.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Risankizumab.
Alpelisib Alpelisib The metabolism of Alpelisib can be increased when combined with Vinblastine.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Vinblastine.
Darolutamide Darolutamide The serum concentration of Darolutamide can be increased when it is combined with Vinblastine.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Vinblastine.
Entrectinib Entrectinib The metabolism of Entrectinib can be increased when combined with Vinblastine.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be increased when combined with Vinblastine.
Istradefylline Istradefylline The serum concentration of Istradefylline can be increased when it is combined with Vinblastine.
Pitolisant Pitolisant The serum concentration of Vinblastine can be decreased when it is combined with Pitolisant.
Fedratinib Fedratinib The serum concentration of Fedratinib can be increased when it is combined with Vinblastine.
Lefamulin Lefamulin The serum concentration of Lefamulin can be increased when it is combined with Vinblastine.
Phenytoin Injection Phenytoin Injection The metabolism of Phenytoin can be increased when combined with Vinblastine.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Vinblastine.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Enfortumab vedotin can be increased when it is combined with Vinblastine.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be increased when combined with Vinblastine.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Vinblastine.
Lumateperone Lumateperone The serum concentration of Lumateperone can be decreased when it is combined with Vinblastine.
Lasmiditan Lasmiditan The serum concentration of Vinblastine can be increased when it is combined with Lasmiditan.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Vinblastine.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Vinblastine.
Cenobamate Cenobamate The serum concentration of Vinblastine can be decreased when it is combined with Cenobamate.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Vinblastine is combined with Ozanimod.
Selumetinib Selumetinib The serum concentration of Selumetinib can be increased when it is combined with Vinblastine.
Rimegepant Rimegepant The metabolism of Rimegepant can be increased when combined with Vinblastine.
Tucatinib Tucatinib Vinblastine may decrease the excretion rate of Tucatinib which could result in a higher serum level.
Remdesivir Injection Remdesivir Injection The serum concentration of Remdesivir can be increased when it is combined with Vinblastine.
Ripretinib Ripretinib The serum concentration of Vinblastine can be increased when it is combined with Ripretinib.
Selpercatinib Selpercatinib The serum concentration of Selpercatinib can be decreased when it is combined with Vinblastine.
Capmatinib Capmatinib The serum concentration of Capmatinib can be decreased when it is combined with Vinblastine.
Lemborexant Lemborexant The serum concentration of Lemborexant can be decreased when it is combined with Vinblastine.
Fostemsavir Fostemsavir The serum concentration of Vinblastine can be increased when it is combined with Fostemsavir.
Octreotide Octreotide The serum concentration of Vinblastine can be increased when it is combined with Octreotide.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Vinblastine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib The serum concentration of Vinblastine can be increased when it is combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Vinblastine can be decreased when it is combined with Satralizumab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be decreased when combined with Vinblastine.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) The metabolism of Vinblastine can be increased when combined with Vitamin E.
Theophylline Theophylline The metabolism of Theophylline can be increased when combined with Vinblastine.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Vinblastine.
Naproxen Naproxen Vinblastine may decrease the excretion rate of Naproxen which could result in a higher serum level.
Trazodone Trazodone The serum concentration of Trazodone can be decreased when it is combined with Vinblastine.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Vinblastine is combined with Hydroxyurea.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Vinblastine.
Phenobarbital Phenobarbital The metabolism of Vinblastine can be increased when combined with Phenobarbital.
Methotrexate Injection Methotrexate Injection The metabolism of Vinblastine can be decreased when combined with Methotrexate.
Primidone Primidone The metabolism of Vinblastine can be increased when combined with Primidone.
Chlorpromazine Chlorpromazine The metabolism of Vinblastine can be increased when combined with Chlorpromazine.
Diazepam Diazepam The metabolism of Vinblastine can be decreased when combined with Diazepam.
Lorazepam Lorazepam The metabolism of Lorazepam can be decreased when combined with Vinblastine.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Vinblastine.
Codeine Codeine The metabolism of Codeine can be decreased when combined with Vinblastine.
Bromocriptine Bromocriptine The metabolism of Vinblastine can be decreased when combined with Bromocriptine.
Tranylcypromine Tranylcypromine The metabolism of Vinblastine can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Vinblastine can be decreased when combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Vinblastine is combined with Procarbazine.
Tetracycline Tetracycline The metabolism of Vinblastine can be decreased when combined with Tetracycline.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Vinblastine.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Vinblastine.
Thioridazine Thioridazine The metabolism of Thioridazine can be decreased when combined with Vinblastine.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Vinblastine.
Oxycodone Oxycodone The metabolism of Oxycodone can be decreased when combined with Vinblastine.
Methadone Methadone The metabolism of Methadone can be increased when combined with Vinblastine.
Oxybutynin Oxybutynin The metabolism of Vinblastine can be decreased when combined with Oxybutynin.
Benztropine Benztropine The metabolism of Benzatropine can be decreased when combined with Vinblastine.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Vinblastine.
Orphenadrine Orphenadrine The metabolism of Vinblastine can be decreased when combined with Orphenadrine.
Perphenazine Perphenazine The metabolism of Perphenazine can be decreased when combined with Vinblastine.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Vinblastine is combined with Azathioprine.
Phentermine Phentermine The metabolism of Phentermine can be decreased when combined with Vinblastine.
Amoxapine Amoxapine The metabolism of Amoxapine can be decreased when combined with Vinblastine.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Vinblastine is combined with Sulfasalazine.
Hydrocortisone Hydrocortisone The metabolism of Vinblastine can be increased when combined with Hydrocortisone.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Vinblastine is combined with Lomustine.
Doxorubicin Doxorubicin The metabolism of Doxorubicin can be increased when combined with Vinblastine.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Vinblastine is combined with Cytarabine.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Vinblastine is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Vinblastine is combined with Dactinomycin.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be increased when combined with Vinblastine.
Clonidine Clonidine The metabolism of Clonidine can be increased when combined with Vinblastine.
Hydralazine Hydralazine The metabolism of Vinblastine can be decreased when combined with Hydralazine.
Cimetidine Cimetidine The metabolism of Vinblastine can be decreased when combined with Cimetidine.
Warfarin Warfarin The metabolism of Warfarin can be increased when combined with Vinblastine.
Clonazepam Clonazepam The metabolism of Clonazepam can be increased when combined with Vinblastine.
Loperamide Loperamide The metabolism of Loperamide can be decreased when combined with Vinblastine.
Promethazine Promethazine The metabolism of Promethazine can be decreased when combined with Vinblastine.
Daunorubicin Daunorubicin The metabolism of Daunorubicin can be decreased when combined with Vinblastine.
Nitrofurantoin Nitrofurantoin Vinblastine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Griseofulvin Griseofulvin The metabolism of Vinblastine can be increased when combined with Griseofulvin.
Digoxin Digoxin Vinblastine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loxapine Loxapine The serum concentration of Vinblastine can be increased when it is combined with Loxapine.
Chloroquine Chloroquine The metabolism of Chloroquine can be decreased when combined with Vinblastine.
Quinine Quinine The metabolism of Vinblastine can be increased when combined with Quinine.
Calcitriol Calcitriol The metabolism of Vinblastine can be increased when combined with Calcitriol.
Sulfinpyrazone Sulfinpyrazone The metabolism of Sulfinpyrazone can be increased when combined with Vinblastine.
Chlorothiazide Chlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Vinblastine.
Isosorbide Isosorbide The metabolism of Isosorbide can be increased when combined with Vinblastine.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be increased when combined with Vinblastine.
Secobarbital Secobarbital The metabolism of Vinblastine can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Vinblastine.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Vinblastine.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Vinblastine.
Probenecid Probenecid The metabolism of Vinblastine can be increased when combined with Probenecid.
Quinidine Quinidine The metabolism of Quinidine can be increased when combined with Vinblastine.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Vinblastine.
Isoniazid Isoniazid The metabolism of Vinblastine can be decreased when combined with Isoniazid.
Rifampin Rifampin The metabolism of Vinblastine can be increased when combined with Rifampicin.
Valproic Acid Valproic Acid The metabolism of Vinblastine can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be increased when combined with Vinblastine.
Mitomycin Mitomycin The risk or severity of bronchospasm, shortness of breath, and dyspnea can be increased when Vinblastine is combined with Mitomycin.
Levothyroxine Levothyroxine The serum concentration of Vinblastine can be decreased when it is combined with Levothyroxine.
Liothyronine Liothyronine The excretion of Liothyronine can be decreased when combined with Vinblastine.
Methimazole Methimazole The metabolism of Methimazole can be decreased when combined with Vinblastine.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Vinblastine.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Vinblastine.
Dinoprostone Dinoprostone The excretion of Dinoprostone can be decreased when combined with Vinblastine.
Niacin Niacin The metabolism of Vinblastine can be decreased when combined with Niacin.
Chlorpheniramine Chlorpheniramine The metabolism of Chlorpheniramine can be decreased when combined with Vinblastine.
Meclizine Meclizine The metabolism of Meclizine can be decreased when combined with Vinblastine.
Methyclothiazide Methyclothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Vinblastine.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Vinblastine.
Chlorzoxazone Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Vinblastine.
Danazol Danazol The metabolism of Vinblastine can be decreased when combined with Danazol.
Disulfiram Disulfiram Vinblastine may decrease the excretion rate of Disulfiram which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Propranolol can be decreased when combined with Vinblastine.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be increased when combined with Vinblastine.
Spironolactone Spironolactone Vinblastine may decrease the excretion rate of Spironolactone which could result in a higher serum level.
Amphotericin B Injection Amphotericin B Injection The metabolism of Vinblastine can be decreased when combined with Amphotericin B.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Vinblastine is combined with Mercaptopurine.
Nadolol Nadolol The metabolism of Nadolol can be decreased when combined with Vinblastine.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Vinblastine.
Clomiphene Clomiphene The serum concentration of Clomifene can be increased when it is combined with Vinblastine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Vinblastine.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Vinblastine.
Cefaclor Cefaclor Vinblastine may decrease the excretion rate of Cefaclor which could result in a higher serum level.
Cephalexin Cephalexin The metabolism of Cephalexin can be decreased when combined with Vinblastine.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Vinblastine is combined with Dacarbazine.
Acetazolamide Acetazolamide The metabolism of Vinblastine can be decreased when combined with Acetazolamide.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Vinblastine.
Ketoconazole Ketoconazole The metabolism of Ketoconazole can be decreased when combined with Vinblastine.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be increased when combined with Vinblastine.
Vincristine Injection Vincristine Injection The metabolism of Vincristine can be increased when combined with Vinblastine.
Dipyridamole Dipyridamole Vinblastine may decrease the excretion rate of Dipyridamole which could result in a higher serum level.
Metoprolol Metoprolol The metabolism of Metoprolol can be decreased when combined with Vinblastine.
Aspirin Aspirin The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Vinblastine.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Vinblastine.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Vinblastine.
Diltiazem Diltiazem The metabolism of Diltiazem can be decreased when combined with Vinblastine.
Nifedipine Nifedipine The metabolism of Nifedipine can be increased when combined with Vinblastine.
Timolol Timolol The metabolism of Timolol can be decreased when combined with Vinblastine.
Verapamil Verapamil The metabolism of Verapamil can be decreased when combined with Vinblastine.
Atenolol Atenolol Vinblastine may decrease the excretion rate of Atenolol which could result in a higher serum level.
Pindolol Pindolol The metabolism of Pindolol can be decreased when combined with Vinblastine.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Vinblastine.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Vinblastine.
Etoposide Etoposide The metabolism of Etoposide can be increased when combined with Vinblastine.
Glyburide Glyburide The metabolism of Glyburide can be decreased when combined with Vinblastine.
Glipizide Glipizide Vinblastine may decrease the excretion rate of Glipizide which could result in a higher serum level.
Dicloxacillin Dicloxacillin The metabolism of Vinblastine can be increased when combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The metabolism of Vinblastine can be increased when combined with Nafcillin.
Pentoxifylline Pentoxifylline The risk or severity of bleeding can be increased when Pentoxifylline is combined with Vinblastine.
Pentamidine Injection Pentamidine Injection The metabolism of Pentamidine can be decreased when combined with Vinblastine.
Labetalol Labetalol The metabolism of Labetalol can be decreased when combined with Vinblastine.
Pimozide Pimozide The metabolism of Pimozide can be increased when combined with Vinblastine.
Enalapril Enalapril The excretion of Enalapril can be decreased when combined with Vinblastine.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Vinblastine.
Buspirone Buspirone The metabolism of Buspirone can be decreased when combined with Vinblastine.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Vinblastine.
Ciprofloxacin Ciprofloxacin The metabolism of Vinblastine can be decreased when combined with Ciprofloxacin.
Diclofenac Diclofenac Vinblastine may decrease the excretion rate of Diclofenac which could result in a higher serum level.
Fluoxetine Fluoxetine The metabolism of Fluoxetine can be decreased when combined with Vinblastine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Vinblastine.
Clozapine Clozapine The risk or severity of neutropenia can be increased when Vinblastine is combined with Clozapine.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Vinblastine is combined with Idarubicin.
Ofloxacin Ofloxacin Vinblastine may decrease the excretion rate of Ofloxacin which could result in a higher serum level.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Vinblastine.
Clarithromycin Clarithromycin The metabolism of Clarithromycin can be decreased when combined with Vinblastine.
Felodipine Felodipine The metabolism of Felodipine can be decreased when combined with Vinblastine.
Pravastatin Pravastatin Vinblastine may decrease the excretion rate of Pravastatin which could result in a higher serum level.
Simvastatin Simvastatin The serum concentration of Simvastatin can be increased when it is combined with Vinblastine.
Filgrastim Injection Filgrastim Injection The risk or severity of peripheral neuropathy can be increased when Filgrastim is combined with Vinblastine.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinblastine.
Amlodipine Amlodipine The metabolism of Amlodipine can be increased when combined with Vinblastine.
Teniposide Injection Teniposide Injection The metabolism of Vinblastine can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Itraconazole can be decreased when combined with Vinblastine.
Sargramostim Sargramostim The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinblastine.
Rifabutin Rifabutin The metabolism of Vinblastine can be increased when combined with Rifabutin.
Sotalol Sotalol The metabolism of Sotalol can be decreased when combined with Vinblastine.
Bisoprolol Bisoprolol The serum concentration of Bisoprolol can be increased when it is combined with Vinblastine.
Zolpidem Zolpidem The metabolism of Zolpidem can be increased when combined with Vinblastine.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Vinblastine.
Isradipine Isradipine The metabolism of Isradipine can be decreased when combined with Vinblastine.
Omeprazole Omeprazole The metabolism of Vinblastine can be increased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Vinblastine can be decreased when combined with Cisapride.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Vinblastine.
Venlafaxine Venlafaxine The metabolism of Venlafaxine can be decreased when combined with Vinblastine.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Vinblastine.
Fluvoxamine Fluvoxamine The metabolism of Fluvoxamine can be decreased when combined with Vinblastine.
Nefazodone Nefazodone The metabolism of Nefazodone can be decreased when combined with Vinblastine.
Losartan Losartan The metabolism of Losartan can be decreased when combined with Vinblastine.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Vinblastine.
Vinorelbine Injection Vinorelbine Injection The metabolism of Vinblastine can be increased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Vinblastine is combined with Carboplatin.
Lansoprazole Lansoprazole The metabolism of Vinblastine can be increased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be increased when combined with Vinblastine.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Vinblastine.
Nicardipine Nicardipine The metabolism of Nicardipine can be decreased when combined with Vinblastine.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be decreased when combined with Vinblastine.
Saquinavir Saquinavir The metabolism of Vinblastine can be decreased when combined with Saquinavir.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Vinblastine.
Glimepiride Glimepiride Vinblastine may decrease the excretion rate of Glimepiride which could result in a higher serum level.
Anastrozole Anastrozole The risk or severity of cardiotoxicity can be increased when Vinblastine is combined with Anastrozole.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Vinblastine.
Indinavir Indinavir Vinblastine may decrease the excretion rate of Indinavir which could result in a higher serum level.
Ritonavir Ritonavir The serum concentration of Vinblastine can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be increased when combined with Vinblastine.
Clomipramine Clomipramine The metabolism of Clomipramine can be increased when combined with Vinblastine.
Zafirlukast Zafirlukast The metabolism of Vinblastine can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine The metabolism of Mirtazapine can be decreased when combined with Vinblastine.
Topiramate Topiramate The metabolism of Vinblastine can be increased when combined with Topiramate.
Valsartan Valsartan The excretion of Valsartan can be decreased when combined with Vinblastine.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Vinblastine.
Nelfinavir Nelfinavir Vinblastine may decrease the excretion rate of Nelfinavir which could result in a higher serum level.
Fexofenadine Fexofenadine The serum concentration of Fexofenadine can be increased when it is combined with Vinblastine.
Azithromycin Azithromycin The metabolism of Azithromycin can be decreased when combined with Vinblastine.
Loratadine Loratadine Vinblastine may decrease the excretion rate of Loratadine which could result in a higher serum level.
Carvedilol Carvedilol The serum concentration of Vinblastine can be increased when it is combined with Carvedilol.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Vinblastine.
Bicalutamide Bicalutamide The metabolism of Vinblastine can be decreased when combined with Bicalutamide.
Sertraline Sertraline The metabolism of Sertraline can be decreased when combined with Vinblastine.
Propafenone Propafenone The serum concentration of Vinblastine can be increased when it is combined with Propafenone.
Raloxifene Raloxifene The metabolism of Raloxifene can be decreased when combined with Vinblastine.
Irbesartan Irbesartan The metabolism of Vinblastine can be decreased when combined with Irbesartan.
Tamsulosin Tamsulosin The metabolism of Tamsulosin can be decreased when combined with Vinblastine.
Quetiapine Quetiapine The metabolism of Quetiapine can be decreased when combined with Vinblastine.
Paroxetine Paroxetine The metabolism of Paroxetine can be decreased when combined with Vinblastine.
Citalopram Citalopram The metabolism of Citalopram can be decreased when combined with Vinblastine.
Capecitabine Capecitabine The risk or severity of adverse effects can be increased when Vinblastine is combined with Capecitabine.
Efavirenz Efavirenz The metabolism of Efavirenz can be increased when combined with Vinblastine.
Sildenafil Sildenafil The serum concentration of Vinblastine can be increased when it is combined with Sildenafil.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Vinblastine.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Vinblastine which could result in a higher serum level.
Rosiglitazone Rosiglitazone Vinblastine may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
Tolterodine Tolterodine The metabolism of Tolterodine can be decreased when combined with Vinblastine.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Vinblastine is combined with Thalidomide.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Vinblastine.
Galantamine Galantamine The metabolism of Galantamine can be decreased when combined with Vinblastine.
Rabeprazole Rabeprazole The metabolism of Vinblastine can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Vinblastine can be increased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists